The aim of this study is to compare the efficacy of paraffin therapy, a physical therapy modality, and ultrasound-guided corticosteroid injection in the treatment of carpal tunnel syndrome, the most common entrapment neuropathy. By doing so, the study will evaluate the effectiveness and feasibility of these two alternative, low-side-effect treatments for managing this frequently encountered condition.
Patients aged 18-65.
Diagnosed with mild to moderate carpal tunnel syndrome based on electrophysiological studies.
Received either ultrasound-guided corticosteroid injection or paraffin therapy.
Symptoms persisting for at least 3 months.
Diagnosis of other conditions causing neuropathic symptoms (e.g., polyneuropathy, brachial plexopathy, thoracic outlet syndrome).
History of previous injection or surgery for carpal tunnel syndrome.
Mild and moderate carpal tunnel syndrome
Other
Cross-sectional
No intervention
Other interventionNo intervention
Visual Analog Scale (VAS):
The VAS will be used to measure pain intensity. Patients will mark their pain level on a 10 cm scale, where 0 represents "no pain" and 10 represents the "worst imaginable pain." This will be evaluated at baseline, and at the 4th and 12th weeks post-treatment.
Boston Carpal Tunnel Syndrome Questionnaire Symptom Severity Scale (BCTQ-SSS)
The SSS assesses the severity of carpal tunnel symptoms such as pain, tingling, and numbness. The total score for this scale ranges from a minimum of 11 to a maximum of 55. A lower score indicates mild or no symptoms, while a higher score suggests more severe symptoms. As the score increases, the severity of symptoms worsens, with a score closer to 55 reflecting a significantly greater impact on daily life.
Boston Carpal Tunnel Syndrome Questionnaire Functional Status Scale (BCTQ-FSS)
The SSS assesses the severity of carpal tunnel symptoms such as pain, tingling, and numbness. The total score for this scale ranges from a minimum of 11 to a maximum of 55. A lower score indicates mild or no symptoms, while a higher score suggests more severe symptoms. As the score increases, the severity of symptoms worsens, with a score closer to 55 reflecting a significantly greater impact on daily life.
Median nerve distal motor latency
It is a finding from electrophysiological evaluation
Median nerve distal sensory latency
It is a finding from electrophysiological evaluation
Sensory nerve conduction velocity
It is a finding from electrophysiological evaluation
Motor nerve conduction velocity
It is a finding from electrophysiological evaluation
Click on the lead sponsor to view all of their trials.
